Mylan Inc. (MYL) said its Canadian subsidiary, Mylan Pharmaceuticals ULC, has received approval from Health Canada for Mylan-Bosentan Tablets, 62.5 mg and 125 mg.
Mylan-Bosentan is the generic version of Actelion Pharmaceuticals Ltd.'s Tracleer, used for the treatment of pulmonary arterial hypertension.
"Providing Canadians access to high quality, affordable medicines is our primary goal," said Dick Guest, Mylan Canada's President and CEO. "By providing access to more affordable generic drugs, Mylan helps to reduce the burden on our health care system, benefiting all Canadians."
For comments and feedback: editorial@rttnews.com